Clinical Trials Logo

Filter by:
NCT ID: NCT06025669 Completed - Sleep Restriction Clinical Trials

Effects of Nap Restriction on Preschoolers' Empathy, Prosocial Behaviors and Executive Function

Start date: September 6, 2023
Phase: N/A
Study type: Interventional

Cross-sectional evidences suggest a relationship between early childhood sleep and cognitive as well as socio-emotional functions. However, the casual relation has not been fully revealed. The current study aims to perform a randomized lab-based crossover nap restriction study on preschoolers, to determine the effects of sleep restriction on preschoolers empathy, prosocial behaviors as well as executive functions.

NCT ID: NCT06025461 Completed - Breast Disease Clinical Trials

Multimodal Ultrasound Diagnosis Characteristics of Bi-rads Class 4 Breast Lesions

Start date: November 15, 2021
Phase:
Study type: Observational

Objective: To explore the potential association between the multimodal ultrasound characteristics and pathological classification of BI-RADS category 4 breast lesions, so as to clarify the diagnostic characteristics of multimodal ultrasound in different pathological types BI-RADS category 4 breast lesions. Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.

NCT ID: NCT06025188 Completed - Develop a Nomogram Clinical Trials

Development and Validation of a Nomogram Predicting the Probability of in Hirschsprung Children Following Surgery

Start date: July 1, 2021
Phase:
Study type: Observational

Postoperative soiling is a common complication following Hirschsprung disease [HSCR] surgery. The aim of this study was to develop a nomogram for predicting the probability of postoperative soiling in patients aged >1 year operated for HSCR. The investigators retrospectively analyzed HSCR patients with surgical therapy over one year of age from January 2000 and December 2019 at our department. Eligible patients were randomly categorized into the training and validation set at a ratio of 7:3. By integrating the least absolute shrinkage and selection operator [LASSO] and multivariable logistic regression analysis, crucial variables were determined for establishment of nomogram. And, the performance of nomogram was evaluated by C-index,area under the receiver operating characteristic curve [ROC], calibration curves, and decision curve analysis [DCA]. Meanwhile, a validation set was used to further assess the model.

NCT ID: NCT06024902 Completed - Severe Asthma Clinical Trials

Clinical Characteristics of Severe Childhood Asthma

Start date: January 1, 2021
Phase:
Study type: Observational

Asthma remains a serious health problem with increasing prevalence and incidence. There is limited information about severe asthma among Chinese pediatric patients. In this context, we decided to explore the clinical characteristics and risk factors of severe asthma in children. This is a descriptive, observational, retrospective cohort study in children with asthma. The purpose of this retrospective study is: to determine the clinical characteristics of severe asthma of children; to identify the factors associated with severe childhood asthma.

NCT ID: NCT06023797 Completed - Lung Cancer Clinical Trials

Neoadjuvant Immunochemotherapy for Lung Cancer

Start date: January 2017
Phase:
Study type: Observational

We retrospectively analyzed lung cancer patients who had NAICT and surgery in the Department of Thoracic Surgery, Zhongshan Hospital. NAICT was defined as chemotherapy that included at one application of PD-1 inhibitor.

NCT ID: NCT06023173 Completed - Clinical trials for The Patients With CRLM Who Benefit More From Bevacizumab

Deep Radiomics-based Fusion Model Predicting Bevacizumab Treatment Response and Outcome in Patients With Colorectal Liver Metastases

Start date: October 1, 2013
Phase:
Study type: Observational

This multi-modal deep radiomics model, using PET/CT, clinical and histopathological data, was able to identify patients with bevacizumab-sensitive unresectable colorectal cancer liver metastases, providing a favorable approach for precise patient treatment.

NCT ID: NCT06023121 Completed - Gastric Cancer Clinical Trials

Use of a Liquid Biopsy Signature to Detect Early-onset Gastric Cancer

Start date: January 1, 2018
Phase:
Study type: Observational

Early-onset gastric cancer (EOGC) is a lethal malignancy with a poor prognosis. It differs from late-onset gastric cancer (LOGC) in clinical and molecular characteristics. The current strategies for EOGC detection have certain limitations in diagnostic performance due to the rising trend in EOGC. Hence, identifying novel EOGC bioindicators is crucial.

NCT ID: NCT06022692 Completed - Clinical trials for Gastrointestinal Tumor

Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours

HEAIS001
Start date: June 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Gastrointestinal tumours (GITs) are the most common and fatal cancers worldwide; 96% of GITs show the microsatellite-stable (MSS)/proficient mismatch repair (pMMR) phenotype, and these tumours have a poor response to immune checkpoint inhibitor (ICI) therapy. Hyperthermia combined with ICI treatment (HIT) has been reported to show a synergistic sensitisation effect in numerous basic studies. This study aimed to validate the effectiveness, safety, and feasibility of water-filtered infrared A radiation (WIRA) whole-body hyperthermia combined with PD-1 inhibitor therapy and evaluate the real-world clinical application prospects of HIT. This open-label single-arm phase 2 clinical trial aimed to enrol advanced GIT patients with the MSS/pMMR phenotype in the East Asian population who had received third-line or higher treatment. The patients were treated with whole-body hyperthermia on days 1 and 8 of each HIT cycle along with administration of tislelizumab 200 mg on day 2 (24 h after the hyperthermia at day 1). The primary outcome was the disease control rate (DCR), while the secondary outcomes were progression-free survival (PFS), overall survival (OS), safety, and improvement in quality of life.

NCT ID: NCT06021574 Completed - Healthy Clinical Trials

A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody

Start date: June 28, 2019
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to study the tolerability, safety, pharmacokinetics and immunogenicity of investigational drug in healthy subjects. The main questions it aims to answer are: - Safety and tolerability of investigational drug. - pharmacokinetics and immunogenicity of investigational drug. Participants will receive a single intravenous administration of investigational drug or placebo. Blood samples are collected at specified time points.

NCT ID: NCT06020365 Completed - Clinical trials for Fecal Microbiota Transplantation

Investigation of Fecal Microbiota Transplant in Chronic Intestinal Pseudo-obstruction Patients

FMT-CIP
Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Chronic Intestinal Pseudo-Obstruction (CIPO) is a rare gastrointestinal disorder that primarily affects the movement of the intestines, leading to symptoms that resemble a true bowel obstruction but without a physical blockage. This condition is characterized by impaired motility of the gastrointestinal tract, which can result in severe symptoms and complications. In previous studies, the investigator found that sequential microbiota transplantation therapy can improve clinical symptoms of chronic pseudo-obstruction. Building on this foundation, the current study further investigates the effects of sequential interventions involving intestinal cleansing, small intestine bacterial treatment, fecal microbiota transplantation, and nutritional therapy on the short-term and long-term clinical symptom improvement in patients. Additionally, the investigator aim to elucidate the changes in gut microbiota phenotypes before and after treatment.